hepatitis C

Systematic review of seroprevalence of markers of hepatitis B, C and HIV among oncohematological patients

Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):131-141
10.36488/cmac.2023.2.131-141
The purpose of systematic review was to assess the incidence of blood-borne infections in oncohematological patients in the period from 1980 to 2020 in different countries of the world, including in main oncohematological clinical groups of patients, …

Hepatitis C in immunocompromised pediatric patients: an epidemiological analysis of data from a center of pediatric hematology, oncology and immunology

Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(4):340-346
10.36488/cmac.2021.4.340-346
Objective. To analyze the incidence of HCV in patients of the «Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology» (Center), to compare with the overall population incidence of HCV, to identify risk factors and risk groups of HCV infection in the Center’s patients. Materials and Methods. A retrospective analysis of the HCV incidence of HCV patients of the Center who were admitted to the Center between 01.

The prevalence of parenteral hepatitis markers among the medical personnel in the Russian Federation regions with different intensity of epidemic process

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):161-167
The results of hepatitis markers prevalence estimation and the immune response intensity and duration in hospital staff (Buryatiya, Ulan-Ude, n=611 and Moscow, n=653) after vaccination against hepatitis B are presented. HBV serological markers were …